Please assess the completion status of the following clinical trial:

Trial Title: Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients (equal or older than 18 years) of both sexes admitted in the Department of Clinical Hematology who develop a febrile neutropenia. Including fever with unknown source and fever secondary to infection focus of clinical diagnosis without laboratory confirmation.~* Informed consent signed.~Exclusion Criteria:~* Fever with etiologic diagnosis.~* Patients with epilepsy.~* Pregnant or lactating women.~* Patients with HIV infection.~* Patients with severe renal failure.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental Arm (Type: EXPERIMENTAL): Empirical antimicrobial treatment discontinuation
- Control Arm (Type: ACTIVE_COMPARATOR): Standard empirical antimicrobial treatment discontinuation

Based on this trial design, predict the completion outcome and termination type (if applicable).